Asarina Pharma AB (publ) - ESG Rating & Company Profile powered by AI
Other corporations in the rating peer group for Asarina Pharma AB (publ) are shownin the table. This analysis of Asarina Pharma AB (publ) employs data from across the web as well as from available filings by Asarina Pharma AB (publ). The SDG assessment for Asarina Pharma AB (publ) represents the company's transparency towards the UN Sustainable Development Goals.
Asarina Pharma AB (publ) in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.8; made up of an environmental score of 0.0, social score of 0.0 and governance score of 5.3.
1.8
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1617 | Berry Genomics Co Ltd | 1.9 | Low |
1617 | scPharmaceuticals Inc | 1.9 | Low |
1631 | Asarina Pharma AB (publ) | 1.8 | Low |
1631 | Cannabis Global, Inc. | 1.8 | Low |
1631 | Cannabis Strategic Ventures | 1.8 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Asarina Pharma AB (publ) have an accelerator or VC vehicle to help deliver innovation?
Does Asarina Pharma AB (publ) disclose current and historical energy intensity?
Does Asarina Pharma AB (publ) report the average age of the workforce?
Does Asarina Pharma AB (publ) reference operational or capital allocation in relation to climate change?
Does Asarina Pharma AB (publ) disclose its ethnicity pay gap?
Does Asarina Pharma AB (publ) disclose cybersecurity risks?
Does Asarina Pharma AB (publ) offer flexible work?
Does Asarina Pharma AB (publ) have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Asarina Pharma AB (publ) disclose the number of employees in R&D functions?
Does Asarina Pharma AB (publ) conduct supply chain audits?
Does Asarina Pharma AB (publ) disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Asarina Pharma AB (publ) conduct 360 degree staff reviews?
Does Asarina Pharma AB (publ) disclose the individual responsible for D&I?
Does Asarina Pharma AB (publ) disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Asarina Pharma AB (publ) disclose current and / or historical scope 2 emissions?
Does Asarina Pharma AB (publ) disclose water use targets?
Does Asarina Pharma AB (publ) have careers partnerships with academic institutions?
Did Asarina Pharma AB (publ) have a product recall in the last two years?
Does Asarina Pharma AB (publ) disclose incidents of discrimination?
Does Asarina Pharma AB (publ) allow for Work Councils/Collective Agreements to be formed?
Has Asarina Pharma AB (publ) issued a profit warning in the past 24 months?
Does Asarina Pharma AB (publ) disclose parental leave metrics?
Does Asarina Pharma AB (publ) disclose climate scenario or pathway analysis?
Does Asarina Pharma AB (publ) disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Asarina Pharma AB (publ) disclose the pay ratio of women to men?
Does Asarina Pharma AB (publ) support suppliers with sustainability related research and development?
Does Asarina Pharma AB (publ) disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Asarina Pharma AB (publ) reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Asarina Pharma AB (publ) involved in embryonic stem cell research?
Does Asarina Pharma AB (publ) disclose GHG and Air Emissions intensity?
Does Asarina Pharma AB (publ) disclose its waste policy?
Does Asarina Pharma AB (publ) report according to TCFD requirements?
Does Asarina Pharma AB (publ) disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Asarina Pharma AB (publ) disclose energy use targets?
Does Asarina Pharma AB (publ) disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Asarina Pharma AB (publ) have a policy relating to cyber security?
Have a different question?
Potential Risks for Asarina Pharma AB (publ)
These potential risks are based on the size, segment and geographies of the company.
Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. Asarina Pharma AB (publ) was incorporated in 2005 and is based in Solna, Sweden.